http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Juneau Construction Company Celebrates Project Completion as National Center for Civil and Human Rights Reopens
-
Leading SEO Marketing Agency for Law Firms Nationwide
-
Edmunds U-Drags Crowns Corvette ZR1 as Fastest Pure-Gas Car Edmunds Has Ever Run
-
Dallas' Caldwell Cassady & Curry Earns Best Law Firms Selection After Winning $445.5 Million Verdict
-
Hyundai, Hyundai Hope on Wheels, and South Point Hyundai Support Children's Health Initiatives in Central Texas
-
The Salvation Army and Walmart Partner Once Again to Bring Joy and Hope to Families in Need This Holiday Season
-
CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
BexBack Crypto Exchange Launches Double Deposit Promotions: 100% Bonus & $100 First-Deposit Credit, 100x Leverage, No KYC
-
BexBack Crypto Exchange Launches Double Deposit Promotions: 100% Bonus & $100 First-Deposit Credit, 100x Leverage, No KYC
-
Wienerschnitzel Honors Veterans and Active-Duty Military with Free Meal on Veterans Day
-
CREATE Medicines Announces Positive First-in-Human Results for MT-302
-
FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
Bitget Slashes Stock Futures Trading Fees by 90% as Daily Volume Surpasses $300 Million
-
Bluum Unveils 17,000 Sq Ft Phoenix Facility
-
FDA approves DARZALEX Faspro for high-risk smoldering multiple myeloma
-
Gilead's Trodelvy fails to meet primary endpoint in breast cancer study
-
FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma
-
Gilead Provides Update on Phase 3 ASCENT-07 Study
-
WKSP Invites You to Join Its Third Quarter 2025 Earnings Conference Call
-
Mirum presents liver disease drug data at AASLD conference
-
Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting®
-
GILD presents long-term data on Livdelzi for liver disease treatment
-
MAX Power Begins Historic Drilling of Canada’s First-Ever Natural Hydrogen Well
-
CrowdStrike’s Fal.Con 2026 Takes Over Mandalay Bay and Launches the Day Zero Threat Summit
-
Guardant Health to Participate in Upcoming Investor Conferences
-
Gilead’s Livdelzi® Demonstrates Sustained Efficacy in Primary Biliary Cholangitis (PBC), Offering Alkaline Phosphatase (ALP) Reduction, Itch Relief and Potential to Slow Disease Progression
-
Top 3 Best Crypto Presale Tokens to Watch Before 2025
-
National Center for Civil and Human Rights Reopens With Major Expansion and New Galleries
-
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
-
CLPS Incorporation Partners with BEA to Conduct a PoC of "Nibot" in the HKMA's GenA.I. Sandbox
-
Soligenix Announces Recent Accomplishments and Third Quarter 2025 Financial Results
-
Kezar Life Sciences presents trial data at medical conferences
-
Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025
-
Ambetter from Fidelis Care Offers Health Insurance in New York State in 2026
-
New Break Resumes Drilling in the Zavitz Discovery Zone at the Moray Gold Project
-
Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates
-
Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance
-
Vodafone and AST SpaceMobile select Germany for satellite operations center
-
Trip.com Group Shapes Global Travel Trends through AI Innovation, Sustainability and New Consumer Insights at WTM London 2025
-
Vodafone and AST SpaceMobile Announce New EU Satellite Constellation and Select Germany for European Sovereign Satellite Operations Centre
-
Trailbreaker Resources Amends Atsutla Option Agreement
-
iMD Companies Cryptocurrency Cloud Mining Selection Update
-
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Eledon reports Phase 2 kidney transplant trial results for tegoprubart
-
Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting
-
Be Relentless: Bryan Flowers Launches Rage Fight Gear, A Brand Forged in Discipline and Mindset
-
Avino Announces Q3 2025 Financial Results
-
Slate Grocery REIT Posts Q3 2025 Earnings Call Transcript and Investor Update
-
Strategic Resources Files Information Circular for Annual General Meeting
-
The DLC Group Announces Strong Third Quarter Results With 19% Funded Mortgage Volume Growth

